• Accueil >
  • Publications >
  • Ferrocifen stealth LNCs and conventional chemotherapy: A promising combination against multidrug-resistant ovarian adenocarcinoma

Ferrocifen stealth LNCs and conventional chemotherapy: A promising combination against multidrug-resistant ovarian adenocarcinoma

1 oct. 2022International Journal of Pharmaceutics

DOI : 10.1016/j.ijpharm.2022.122164

Auteurs

Pierre Idlas, Abdallah Ladaycia, Fariba Némati, Elise Lepeltier, Pascal Pigeon, Gerard Jaouen, Didier Decaudin, Catherine Passirani